
|Articles|May 22, 2006
MDS: There's light at the end of the tunnel
Where once treatments were lacking for myelodysplastic syndromes,now several drugs have been approved for this bone marrow disorder
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Individualized Approach Helps When Intensifying GLP-1 Therapy in T2D
3
Meta-Analysis Identifies 5 Risk Factors for Post-COVID-19 Condition
4
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
5







































